Glenmark’s third-quarter profit rises 16% on strong performance in India and the US

Glenmark Pharmaceuticals Ltd has reported a 16% rise in consolidated net profit for the third quarter ended December to Rs 403 crore, the drugmaker said in an after-market statement on Friday. Consolidated revenue rose 15% year-on-year to Rs 3,900 crore during the period.The strong quarterly performance was primarily driven by robust growth in the Indian […]

Stocks in news: PNB, ZEE, JSW Steel, REC, Glenmark

Markets started the week on an optimistic note and continued their upward momentum, largely supported by favorable domestic cues. With the Nifty nearing the 26,000-point mark, analysts say some consolidation cannot be ruled out before another breakout. “However, the overall trend remains positive with immediate support around 25,650 and major support around 25,450. We recommend […]

Glenmark, Texmaco Rail Shares in Focus on the last day to buy for a dividend eligible

Glenmark Pharmaceuticals and Texmaco Rail & Engineering shares will be in Focus today, because the last day marks to buy shares to be eligible for their recently announced final dividends. The record date for determining shareholder has been determined for Friday 12 September 2025. Glenmark Pharmaceuticals has declared a definitive dividend of 250% on RS […]